目的 针对软胶囊剂型特点和处方组成,探讨软胶囊溶出度试验方法的适用性,为建立软胶囊质量控制方法提供参考。方法 通过分析各国药典关于软胶囊溶出特性试验的要求,结合近年来国内外相关实验研究进展,对比各国药典软胶囊典型品种的溶出方法的异同。结果 软胶囊溶出特性试验较一般固体口服制剂要复杂,且各国药典对软胶囊溶出特性要求不尽相同,其内容物的处方组成和亲水亲脂性、囊壳的破裂和交联作用、溶出装置等对其溶出特性均有影响。结论 建立软胶囊溶出度试验方法可从溶出装置的选择、溶出介质的选择、破裂试验和体内外相关性等方面进行分析研究。
Abstract
OBJECTIVE To provide references for effective quality control of soft capsules and discuss the applicability of method for dissolution test of soft capsules. METHODS Based on analyzing dissolution requirements of soft capsules, we were compared the differences of METHODS for dissolution test in the pharmacopoeias of several countries with current correlative research from home and abord. RESULTS The dissolution characteristics of soft capsules are more complex than common oral solid dosage forms, and the requirments are different in the pharmacopoeias of several countries. The formula of contents, hydrophilicity, rupture test and crossliking have impacts on the dissolution characteristics as well as dissolution device and so on. CONCLUSION In order to develop the method for dissolution test of soft capsules, the dissolution device and medium, rupture test and in vitro-in vivo correlation etc. should be studied.
关键词
软胶囊 /
溶出度方法 /
研究策略
{{custom_keyword}} /
Key words
soft capsule /
dissolution method /
research strategy
{{custom_keyword}} /
中图分类号:
R917
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] WANG H, HOU H M. Encyclopedia of Pharmaceutical Technology(制剂技术百科全书)[M]. Beijing: Science Press, 2009: 1141-1147.
[2] DONATO E M, MARTINS L A, FRÖEHLICH P E, et al. Development and validation of dissolution test for lopinavir, a poorly water-soluble drug, in soft gel capsules, based on in vivo data[J]. J Pharm Biomed Anal, 2008, 47(3):547-552.
[3] VONDERSCHER J,MEINZER A. Rationale for the development of sandimmune neoral[J]. Transplant Proc, 1994, 26(5):2925-2927.
[4] STELLA V, HASLAM J, YATA N, et al. Enhancement of bioavailability of a hydrophobic amine antimalarial by formulation with oleic acid in a soft capsule[J]. J Pharm Sci, 1978, 67(10):1375-1377.
[5] HUMBERSTONE A J, CHARMAN W N. Lipid based vehicles for the oral delivery of poorly water soluble drugs[J]. Adv Drug Deliv Rev, 1997, 25(1):103-128.
[6] LI H, WANG Y T. Research progress of soft capsules at home and abroad in recent ten years[J]. J Chin Med Inf(中国中医药信息杂志), 2003, 10(2):78-79.
[7] Ch. P(2015) Vol Ⅳ(中国药典2015年版. 四部) [S]. 2015:6.
[8] RAMPURNA P G. Soft gelatin capsules(Softgels)[J]. J Pharm Sci, 2010, 99(10):4107-4148.
[9] Ch.P(2015) Vol Ⅱ(中国药典2015年版. 二部) [S]. 2015:1431-1464.
[10] State Food and Drug Administration. Product-Specific Guidances for Generic Drug Development [EB/OL]. (2017-05-16)[2017-08-15]. https://www.fda.gov/drugs/guidancecomplianceregulatoryinformation/guidances/ucm075207.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery.html.
[11] MARGARETH R C, MARQUES. Enzymes in the dissolution testing of gelatin capsules[J]. AAPS Pharm Sci Tech, 2014, 15(6):1410-1416.
[12] USP 40 Vol Ⅰ[S]. 2016:1316-1324.
[13] MEYER M C, STRAUGHN A B, MHATRE R M, et al. The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules [J]. Pharm Res, 2000, 17(8):962-966.
[14] AZARMI S, ROA W, LÖBENBERG R. Current perspectives in dissolution testing of conventional and novel dosage forms[J]. Inter J Pharm, 2007, 328(1):12-21.
[15] NING B M, ZHANG Q M. Handbook of Dissolution Testing(溶出度试验技术)[M]. 3rd ed. Beijing: Chinese Medical Science and Technology Press, 2007:68.
[16] SIEWERT M, DRESSMAN J, BROWN C K, et al. FIP/AAPS guidelines for dissolution/in vitro release testing of novel/special dosage forms[J]. AAPS Pharm Sci Tech, 2003,10(1):6-15.
[17] ANAND O M, YU L X, CONNER D P, et al. Dissolution testing for generic drugs: an FDA perspective[J]. AAPS J, 2011,13(3):328-335.
[18] BROWN C K, FRIEDEL H D, BARKER A R, et al. FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms[J]. AAPS Pharm Sci Tech, 2011, 12(2):782-794.
[19] SAANO V, PARONEN P, PEURA P, et al. Pharmacokinetics of three oral 400 mg ibuprofen dosage forms in healthy volunteers[J]. Int J Clin Pharmacol Ther Toxicol, 1991, 29(10):381-385.
[20] HU J, KYAD A, KU V, et al. A comparison of dissolution testing on lipid soft gelatin capsules using USP apparatus 2 and apparatus 4[J]. Dissolution Technol, 2005, 12(2):6-9.
[21] TAKAHASHI M, MOCHIZUKI M, WADA K, et al. Studies on dissolution tests of soft gelatin capsules. V. Rotating dialysis cell method[J]. Chem Pharm Bull, 1994, 42(8):1672-1675.
[22] PILLAY V, FASSIHI R. A new method for dissolution studies of lipid-filled capsules employing nifedipine as a model drug[J]. Pharm Res, 1999, 16(2):333-337.
[23] TAKAHASHI M. Studies on dissolution tests for soft gelatin capsules by the rotating dialysis cell(RDC) method. VI. Preparation and evaluation of ibuprofen soft gelatin capsule[J]. Chem Pharm Bull, 1995, 43(8):1398-1401.
[24] TAKAHASHI M. Studies on dissolution tests for soft gelatin capsules.Ⅳ. Dissolution test of nifedipine soft gelatin capsule containing water soluble vehicles by the rotating dialysis cell method[J]. Chem Pharm Bull, 1994, 42(2):333-336.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
浙江省科技厅2017年度省级软科学研究计划项目资助(2017C35074)
{{custom_fund}}